It was a really really really weak attempt at drawing some equivalence, tryng topaiint any and all attempts to reduce gov’t spending as “price contol.”
As if opposing $333,00 outhouses and and $3.6million tilets is “price cotrol.”
Good for Trump trying to bring down the cost of pharmaceuticals. I don’t believe the EO will work though. I’d much rather he go after the nonstop blitz of pharmaceutical ads on TV. Only the US and Argentina allow this type of advertisement.
That’s not true. You can run a small business and not offer anyone insurance.
I wish more people shared this opinion when biden was lowering drug prices for MC/MC because with a little support he might have done an even better job.
I’m so old I remember when the government intervening to reduce rx drug prices was a terrible tragedy that would definitely fail, stifle innovation and lead to higher costs.
Done properly I don’t think the US government “tells” pharma companies what they can charge in order to reduce costs. That would 100% be a price control.
Instead, I think the government negotiates the price, just like they do for Medicare-funded medical services. The government has tremendous purchasing power here - it should be paying among the lowest prices available. Ever since the creation of Part D they’ve been paying the opposite of that.
I was talking about other countries. Maybe price control was the wrong phrase. Many other nations restrict what pharma can charge for drugs and now it seems Trump is moving in the same direction to reduce the insane costs that Americans face for prescriptions.
Trump and Kennedy have it all wrong, of course. Pharma makes its profits, for sure, but PBMs are the culprit for a lot of our pharmacy woes in the US. PBMs are Pharmacy Benefit Managers, middle men, so to speak.
PBMs negotiate rebates with drug manufacturers, and this can influence formularies (lists of covered drugs), potentially favoring higher-cost medications and limiting patient access to lower-cost alternatives. Additionally, PBMs may charge insurers higher amounts for drugs than they reimburse pharmacies, a practice known as “spread pricing,” which contributes to higher costs.
Those rebates go to them, not you. You still pay more. And a lot of PBMs are owned by Insurance carriers, so they double dip. Real conflict of interest. And they tend to favor their own pharmacies and hurt smaller ones, which leads to lowered choices for consumers.
If you just regulate PHARMA it won’t matter much, PBMs are a cancer in the medical field but their influence is so poorly understood they never seem to get the attention they deserve.
I don’t. We shouldn’t be effectively subsidizing Europe so they can get cheap medicine pieces on their universal Euro healthcare by paying way more so they can pay way less. That’s ■■■■■■■■■
“Duh I cannot defeat my opponents so I will make up imaginary words and put those words in their mouths. (snort frool giggle) That way I can make them look stupid and make me look shmart.”
this will be Pepperidged Farmed in a few months. The EO doesn’t actually do anything except direct government to look into it. Just like Trumps insulin drugs reducing EO which was a voluntary measure it took Congress to pass a bill to do it.